These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30648816)

  • 1. The mechanism of ATF3 repression of epithelial-mesenchymal transition and suppression of cell viability in cholangiocarcinoma via p53 signal pathway.
    You Z; Xu J; Li B; Ye H; Chen L; Liu Y; Xiong X
    J Cell Mol Med; 2019 Mar; 23(3):2184-2193. PubMed ID: 30648816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
    Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
    Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
    BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.
    Wu C; Zhang J; Cao X; Yang Q; Xia D
    Med Sci Monit; 2016 Jul; 22():2685-90. PubMed ID: 27472451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
    El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR
    PLoS One; 2013; 8(10):e77433. PubMed ID: 24204826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
    Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
    Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis.
    Qiang Y; Wang F; Yan S; Zhang H; Zhu L; Chen Z; Tu F; Wang D; Wang G; Wang W; Chen Z
    Int J Oncol; 2015; 46(6):2449-58. PubMed ID: 25873280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-125 seed inhibits proliferation and promotes apoptosis of cholangiocarcinoma cells by inducing the ROS/p53 axis.
    Kang F; Wu J; Hong L; Zhang P; Song J
    Funct Integr Genomics; 2024 Jun; 24(3):114. PubMed ID: 38862667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
    Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
    EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin stimulates the epithelial‑mesenchymal transition and pro‑angiogenic capability of cholangiocarcinoma cells through the miR‑122/PKM2 axis.
    Peng C; Sun Z; Li O; Guo C; Yi W; Tan Z; Jiang B
    Int J Oncol; 2019 Jul; 55(1):298-308. PubMed ID: 31115511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0001742 promotes tongue squamous cell carcinoma progression via miR-431-5p/ATF3 axis.
    Hu YT; Li XX; Zeng LW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10300-10312. PubMed ID: 31841185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.